Editas Medicine–Barclays: investor conference, 201703 supply service Editas presents at Barclays Global Healthcare Conference

	Period	2017-03-16
	Region	Miami, FL
	Country	United States (USA)
	Partner, 1st	Editas Medicine Inc. (Nasdaq: EDIT)
	Partner, 2nd	Barclays Capital
	Group	Barclays (Group)
	Product	Barclays Global Healthcare Conference 2017 Miami
	Product 2	genome editing (gene editing)

Editas Medicine, Inc.. (2/27/17). "Press Release: Editas Medicine to Present at Investor Conferences in March". Cambridge, MA.

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in March. Details of the presentations are as follows:

Cowen & Company 37th Annual Healthcare Conference
Date: Monday, March 6, 2017
Time: 2:40 p.m. ET
Location: Boston

Barclays Global Healthcare Conference 2017
Date: Thursday, March 16, 2017
Time: 9:30 a.m. ET
Location: Miami

Live webcasts of the presentations will be available on the Investors & Media section of the Editas website at www.editasmedicine.com. Archived replays will be available for approximately 30 days following the respective presentations.

About Editas Medicine

Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact
Dan Budwick
Pure Communications, Inc.
(973) 271-6085
dan@purecommunicationsinc.com

Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083
mark.mullikin@editasmed.com